PL3463310T3 - Tabletki o wysokiej zawartości składników aktywnych soli aminokwasowych kwasów tłuszczowych omega-3 - Google Patents

Tabletki o wysokiej zawartości składników aktywnych soli aminokwasowych kwasów tłuszczowych omega-3

Info

Publication number
PL3463310T3
PL3463310T3 PL17726906.5T PL17726906T PL3463310T3 PL 3463310 T3 PL3463310 T3 PL 3463310T3 PL 17726906 T PL17726906 T PL 17726906T PL 3463310 T3 PL3463310 T3 PL 3463310T3
Authority
PL
Poland
Prior art keywords
omega
tablets
active ingredient
amino acid
ingredient content
Prior art date
Application number
PL17726906.5T
Other languages
English (en)
Inventor
Thomas Gottstein
Günter Knaup
Michael Schwarm
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Publication of PL3463310T3 publication Critical patent/PL3463310T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL17726906.5T 2016-05-25 2017-05-24 Tabletki o wysokiej zawartości składników aktywnych soli aminokwasowych kwasów tłuszczowych omega-3 PL3463310T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16171296 2016-05-25
PCT/EP2017/062592 WO2017202942A1 (en) 2016-05-25 2017-05-24 Tablets with high active ingredient content of omega-3 fatty acid amino acid salts

Publications (1)

Publication Number Publication Date
PL3463310T3 true PL3463310T3 (pl) 2023-12-04

Family

ID=56081305

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17726906.5T PL3463310T3 (pl) 2016-05-25 2017-05-24 Tabletki o wysokiej zawartości składników aktywnych soli aminokwasowych kwasów tłuszczowych omega-3

Country Status (9)

Country Link
US (1) US12115260B2 (pl)
EP (1) EP3463310B1 (pl)
AU (1) AU2017270134B2 (pl)
CA (1) CA3025425C (pl)
DK (1) DK3463310T3 (pl)
ES (1) ES2956766T3 (pl)
PL (1) PL3463310T3 (pl)
TW (1) TW201808274A (pl)
WO (1) WO2017202942A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220287345A1 (en) * 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
EP4009956A1 (en) * 2019-08-08 2022-06-15 Evonik Operations GmbH Down streaming process for the production of polyunsaturated fatty acid salts
WO2021023850A1 (en) * 2019-08-08 2021-02-11 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
EP3804699A1 (en) * 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
IT1264987B1 (it) 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
US20100215758A1 (en) * 2009-02-25 2010-08-26 Joar Opheim Effervescent nutritional and/or dietary supplement composition

Also Published As

Publication number Publication date
CA3025425A1 (en) 2017-11-30
DK3463310T3 (da) 2023-09-25
AU2017270134B2 (en) 2022-09-01
ES2956766T3 (es) 2023-12-27
AU2017270134A1 (en) 2018-12-06
WO2017202942A1 (en) 2017-11-30
CA3025425C (en) 2024-10-01
US20200315970A1 (en) 2020-10-08
EP3463310B1 (en) 2023-07-05
US12115260B2 (en) 2024-10-15
EP3463310A1 (en) 2019-04-10
TW201808274A (zh) 2018-03-16

Similar Documents

Publication Publication Date Title
PL3720838T3 (pl) Sole organicznych kwasów sulfonowych i estrów aminokwasów i sposoby ich wytwarzania
EP3248598A4 (en) Self-emulsifying composition of omega-3 fatty acid
EP3248599A4 (en) Omega-3 fatty acid self-emulsifying composition
SG11201600337PA (en) SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID
PT3116491T (pt) Composições farmacêuticas de compostos terapeuticamente ativos
SI3346835T1 (sl) Sestavek insekticida/miticida na osnovi soli maščobnih kislin
PL3359632T3 (pl) Kompozycje zawierające aminę cukrową i kwas tłuszczowy
DK3463310T3 (da) Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte
PL3093018T3 (pl) Preparat farmaceutyczny zawierający związki kwasu pirydyloaminooctowego
EP3102227A4 (en) Combination of creatine, an omega-3 fatty acid, and citicoline
ZA201605379B (en) Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
IL266755B (en) A pharmaceutical preparation for parenteral administration containing carglumic acid
IL260766B (en) Continuous production of complexes containing active pharmaceutical ingredients
PT3102187T (pt) Composições farmacêuticas estáveis contendo sitagliptina sob a forma de comprimidos de libertação imediata
SG10202008700VA (en) α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
PL3346979T3 (pl) Wodne kompozycje kosmetyczne zawierające estry kwasu pelargonowego
IL263982B (en) Preparations with two ingredients containing acetylsalicylic acid and sea salt of organic acids
PL3346980T3 (pl) Lipofilowe kompozycje kosmetyczne zawierające estry kwasu pelargonowego
IL249010A0 (en) A pharmaceutical preparation containing a pyrazine carboxamide compound as an active ingredient
GB2546513B (en) Process of preparing active pharmaceutical ingredient salts
ZA201900065B (en) Personal care compositions comprising fatty acid amide derivatives
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
SG10202103821WA (en) SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID